High Tide Inc. (HITI)
NASDAQ: HITI · Real-Time Price · USD
2.650
+0.030 (1.15%)
At close: Dec 31, 2025, 4:00 PM EST
2.678
+0.028 (1.06%)
After-hours: Dec 31, 2025, 7:02 PM EST
High Tide Revenue
High Tide had revenue of 149.69M CAD in the quarter ending July 31, 2025, with 13.67% growth. This brings the company's revenue in the last twelve months to 568.25M, up 11.18% year-over-year. In the fiscal year ending October 31, 2024, High Tide had annual revenue of 522.31M with 7.10% growth.
Revenue (ttm)
568.25M CAD
Revenue Growth
+11.18%
P/S Ratio
0.57
Revenue / Employee
324,714 CAD
Employees
1,750
Market Cap
233.17M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 522.31M | 34.64M | 7.10% |
| Oct 31, 2023 | 487.67M | 130.82M | 36.66% |
| Oct 31, 2022 | 356.85M | 175.73M | 97.02% |
| Oct 31, 2021 | 181.12M | 97.86M | 117.53% |
| Oct 31, 2020 | 83.27M | 51.97M | 166.07% |
| Oct 31, 2019 | 31.29M | 22.55M | 257.69% |
| Oct 31, 2018 | 8.75M | -1.24M | -12.45% |
| Oct 31, 2017 | 9.99M | 1.55M | 18.40% |
| Oct 31, 2016 | 8.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HITI News
- 9 days ago - High Tide Recaps Key Milestones of 2025 - PRNewsWire
- 10 days ago - High Tide to Participate in the ICR Conference in Orlando, Florida - PRNewsWire
- 13 days ago - 3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? - Seeking Alpha
- 14 days ago - High Tide Welcomes Historic Executive Order on Cannabis Rescheduling and Medicare Reimbursements for CBD Products - PRNewsWire
- 23 days ago - Ancillary Cannabis Stocks Poised for Growth Heading Into 2026 - MarijuanaStocks
- 27 days ago - High Tide to Open Three New Canna Cabana Locations - PRNewsWire
- 4 weeks ago - High Tide Opens First European Canna Cabana in Berlin - PRNewsWire
- 4 weeks ago - High Tide: Discount Cannabis Retailer Hiding In Plain Sight - Seeking Alpha